Prof. Crispin Dass

Crispin R. Dass is a Research Professor in the Curtin Medical School at Curtin University. He majored in Medical Biotechnology and received first-class Honours from Charles Sturt University. He then obtained a doctorate in the field of Biomedical Sciences, in the area of cancer therapy, at the same university. He has 33 years of basic and applied research in cancer, 9 years in diabetes, and 7 years in atherosclerosis, molecular techniques, in vivo (small animal) experimentation, cell culture testing and significant drug formulation and delivery skills. He has worked on big pharma projects (Amgen, Novartis, Glaxo-Wellcome, Johnson & Johnson) in drug testing for oncology and atherosclerosis and has original research papers in such journals as Nature Medicine, Journal of the National Cancer Institute, Biomaterials, and Journal of Controlled Release. He has 245 publications with ~16500 citations and an h-index of 55 (Scopus, 29th Feb 2024), plus 45724 reads (Google Scholar, 24th Jan 2024). He has been in a lab leadership role for the past 19 years and has trained around 130 research students and staff on the techniques of cancer, diabetes and cardiovascular disease research and associated cell biology and pharmaceutics in his career.